A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
Clinical trial NCT04699630 · COMPLETED
Trial details
- NCT number
- NCT04699630
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2025-04-09
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.